These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14716644)

  • 41. [Prevention of heterotopic ossifications in hip arthroplasty: effectiveness of selective Cox-2 inhibitors (celecoxib) versus ketoprofen].
    Vastel L; Rosencher N; Siney H; Courpied JP
    Rev Chir Orthop Reparatrice Appar Mot; 2005 Feb; 91(1):64-9. PubMed ID: 15791193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
    Saudan M; Saudan P; Perneger T; Riand N; Keller A; Hoffmeyer P
    J Bone Joint Surg Br; 2007 Feb; 89(2):155-9. PubMed ID: 17322426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
    Barthel T; Baumann B; Nöth U; Eulert J
    Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Celecoxib and heterotopic bone formation after total hip arthroplasty.
    Lavernia CJ; Contreras JS; Villa JM; Rossi MD
    J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
    Romanò CL; Duci D; Romanò D; Mazza M; Meani E
    J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
    Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
    Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach.
    White PB; Ramkumar PN; Meftah M; Ghazi N; Ranawat AS; Ranawat CS
    Orthopedics; 2018 Jan; 41(1):e92-e97. PubMed ID: 29120007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.
    Zhu XT; Chen L; Lin JH
    Medicine (Baltimore); 2018 Aug; 97(31):e11649. PubMed ID: 30075549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis.
    Joice M; Vasileiadis GI; Amanatullah DF
    Bone Joint J; 2018 Jul; 100-B(7):915-922. PubMed ID: 29954195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterotopic ossification in patients after total hip replacement.
    Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
    Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of heterotopic ossification after total hip replacement with NSAIDs.
    Fijn R; Koorevaar RT; Brouwers JR
    Pharm World Sci; 2003 Aug; 25(4):138-45. PubMed ID: 12964491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
    Kjaersgaard-Andersen P; Schmidt SA
    Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Celecoxib, NSAIDs and the skeleton.
    O'Connor JP; Lysz T
    Drugs Today (Barc); 2008 Sep; 44(9):693-709. PubMed ID: 19137124
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.